🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

493 results for “Regeneron UK Limited” Clear

  1. Pozelimab

    Regeneron UK Limited

    CHAPLE Disease

    approved small molecule active

    1 trial

  2. Praluent

    Regeneron UK Limited

    Heterozygous Familial Hypercholesterolemia

    approved small molecule terminated

    1 trial

  3. Praluent (Alirocumab)

    Regeneron UK Limited

    Hypercholesterolemia

    approved small molecule completed

    1 trial

  4. Rescue Intravitreal Aflibercept Injection

    Regeneron UK Limited

    Neovascular Polypoidal Choroidal Vasculopathy

    approved small molecule active

    1 trial

  5. SAR231893

    Regeneron UK Limited

    Asthma

    approved small molecule completed

    1 trial

  6. Sarilumab

    Regeneron UK Limited

    Rheumatoid Arthritis

    approved small molecule terminated

    8 trials

  7. Sarilumab

    Regeneron UK Limited

    Polymyalgia Rheumatica

    approved small molecule active

    1 trial

  8. aflibercept 2.0 mg

    Regeneron UK Limited

    Diabetic Macular Edema

    approved small molecule completed

    1 trial

  9. aflibercept 2.0 mg

    Regeneron UK Limited

    Age Related Macular Degeneration

    approved small molecule completed

    1 trial

  10. dupilumab

    Regeneron UK Limited

    Severe Atopic Dermatitis (AD)

    approved small molecule terminated

    1 trial

  11. dupilumab

    Regeneron UK Limited

    Chronic Obstructive Pulmonary Disease (COPD)

    approved small molecule active

    1 trial

  12. Aspirin

    Regeneron UK Limited

    Healthy Volunteer

    small molecule completed

    1 trial

  13. Gluten Powder

    Regeneron UK Limited

    Celiac Disease

    other completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources